Arch Therapeutics Statistics
Total Valuation
ARTH has a market cap or net worth of $500,006. The enterprise value is $8.53 million.
Market Cap | 500,006 |
Enterprise Value | 8.53M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
ARTH has 555,562 shares outstanding. The number of shares has increased by 255.94% in one year.
Shares Outstanding | 555,562 |
Shares Change (YoY) | +255.94% |
Shares Change (QoQ) | -4.47% |
Owned by Insiders (%) | 3.51% |
Owned by Institutions (%) | 3.38% |
Float | 4.30M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 0.08 |
PS Ratio | 3.83 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 65.35 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
Current Ratio | 0.12 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.62 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -547.45% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $16,318 |
Profits Per Employee | -$1.05M |
Employee Count | 8 |
Asset Turnover | 0.07 |
Inventory Turnover | 0.06 |
Taxes
Income Tax | -1.49M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.25% in the last 52 weeks. The beta is 3.61, so ARTH's price volatility has been higher than the market average.
Beta (5Y) | 3.61 |
52-Week Price Change | -53.25% |
50-Day Moving Average | 1.01 |
200-Day Moving Average | 2.51 |
Relative Strength Index (RSI) | 49.38 |
Average Volume (20 Days) | 1,830 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ARTH had revenue of $130,543 and -$8.43 million in losses. Loss per share was -$2.84.
Revenue | 130,543 |
Gross Profit | 43,572 |
Operating Income | -4.71M |
Pretax Income | -8.43M |
Net Income | -8.43M |
EBITDA | -4.71M |
EBIT | -4.71M |
Loss Per Share | -$2.84 |
Balance Sheet
The company has $26,426 in cash and $8.06 million in debt, giving a net cash position of -$8.03 million or -$14.46 per share.
Cash & Cash Equivalents | 26,426 |
Total Debt | 8.06M |
Net Cash | -8.03M |
Net Cash Per Share | -$14.46 |
Equity (Book Value) | -10.88M |
Book Value Per Share | -19.58 |
Working Capital | -10.88M |
Cash Flow
In the last 12 months, operating cash flow was -$3.69 million and capital expenditures -$4,521, giving a free cash flow of -$3.69 million.
Operating Cash Flow | -3.69M |
Capital Expenditures | -4,521 |
Free Cash Flow | -3.69M |
FCF Per Share | -$0.82 |
Margins
Gross margin is 33.38%, with operating and profit margins of -3,611.58% and -6,458.48%.
Gross Margin | 33.38% |
Operating Margin | -3,611.58% |
Pretax Margin | -6,458.48% |
Profit Margin | -6,458.48% |
EBITDA Margin | -3,609.95% |
EBIT Margin | -3,611.58% |
FCF Margin | -2,827.86% |
Dividends & Yields
ARTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -255.94% |
Shareholder Yield | -255.94% |
Earnings Yield | -1,686.20% |
FCF Yield | -738.31% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 18, 2023. It was a reverse split with a ratio of 1:200.
Last Split Date | Jan 18, 2023 |
Split Type | Reverse |
Split Ratio | 1:200 |
Scores
ARTH has an Altman Z-Score of -78.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -78.66 |
Piotroski F-Score | 3 |